Abstract
Pathogenic Escherichia coli poses a serious threat to global public health and is especially dangerous with the increase of antibiotic resistance. β-Glucuronidase (GUS) and some other glycosidases can serve as useful biomarkers or indicators for the detection of E. coli. The probes made up of a glycosyl residue (recognition group), a label or reporter group, and a linkage that is generally a direct glycosidic bond, are powerful analytical tools. Upon hydrolysis of the glycosidic linkages by the corresponding glycosidases, these probes irreversibly release detectable labels or reporter molecules. A variety of such glycosidase probes have been developed and applied for the detection of E. coli or the development of various corresponding detection methods. This paper provides an overview of recent advances in this field, covering the development and applications of chromogenic, fluorogenic, luminogenic, and electrochemical glycosidase substrates. The challenges and opportunities in the probe development for detection of E. coli are also discussed.
Keywords: Bacterial pathogens, Glycosidase substrates, Chromogenic substrates, Fluorogenic substrates, Luminogenic substrates, Electrochemical substrates.
Current Medicinal Chemistry
Title:Recent Advances in Glycosidase Probes Used in Escherichia Coli Detection
Volume: 28 Issue: 26
Author(s): Xianhu Wei, Ying Feng, Minling Chen, Shuhong Zhang, Moutong Chen, Jumei Zhang, Youxiong Zhang, Qinghua Ye, Yu Ding, Liang Xue and Qingping Wu*
Affiliation:
- Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Guangdong Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070,China
Keywords: Bacterial pathogens, Glycosidase substrates, Chromogenic substrates, Fluorogenic substrates, Luminogenic substrates, Electrochemical substrates.
Abstract: Pathogenic Escherichia coli poses a serious threat to global public health and is especially dangerous with the increase of antibiotic resistance. β-Glucuronidase (GUS) and some other glycosidases can serve as useful biomarkers or indicators for the detection of E. coli. The probes made up of a glycosyl residue (recognition group), a label or reporter group, and a linkage that is generally a direct glycosidic bond, are powerful analytical tools. Upon hydrolysis of the glycosidic linkages by the corresponding glycosidases, these probes irreversibly release detectable labels or reporter molecules. A variety of such glycosidase probes have been developed and applied for the detection of E. coli or the development of various corresponding detection methods. This paper provides an overview of recent advances in this field, covering the development and applications of chromogenic, fluorogenic, luminogenic, and electrochemical glycosidase substrates. The challenges and opportunities in the probe development for detection of E. coli are also discussed.
Export Options
About this article
Cite this article as:
Wei Xianhu , Feng Ying , Chen Minling, Zhang Shuhong , Chen Moutong , Zhang Jumei , Zhang Youxiong , Ye Qinghua , Ding Yu , Xue Liang and Wu Qingping*, Recent Advances in Glycosidase Probes Used in Escherichia Coli Detection, Current Medicinal Chemistry 2021; 28 (26) . https://dx.doi.org/10.2174/0929867328999201224111615
DOI https://dx.doi.org/10.2174/0929867328999201224111615 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Intranasal Fluorescent Nanocrystals for Longitudinal <i>In Vivo</i> Evaluation of Cerebral Microlesions
Pharmaceutical Nanotechnology Delivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke
Current Pharmaceutical Design Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy
Current Drug Targets Fish and Apoptosis: Studies in Disease and Pharmaceutical Design
Current Pharmaceutical Design Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design Nano-Based Anti-Tubercular Drug Delivery and Therapeutic Interventions in Tuberculosis
Current Drug Targets A Review of the Carbapenems in Clinical Use and Clinical Trials
Recent Patents on Anti-Infective Drug Discovery Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Current Neuropharmacology Novel Approaches To Fight Streptococcus pneumoniae
Recent Patents on Anti-Infective Drug Discovery Dementia Etiologies and Remedies in Traditional Persian Medicine; A Review of Medicinal Plants and Phytochemistry
Current Drug Metabolism Methodologies to Assess Brain Drug Delivery in Lead Optimization
Current Topics in Medicinal Chemistry An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy Evaluation of Small Molecule Tuberculostats for Targeting Tuberculosis Infections of the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Saving the Ischemic Penumbra: Potential Role for Statins and Phosphodiesterase Inhibitors
Current Vascular Pharmacology Aquaporin and Vascular Diseases
Current Neuropharmacology Medicinal Use of Lincosamides and Microbial Resistance to Them
Anti-Infective Agents in Medicinal Chemistry Chloramphenicol Enhances IDUA Activity on Fibroblasts from Mucopolysaccharidosis I Patients
Current Pharmaceutical Biotechnology Clinical Pharmacokinetics of Systemically Administered Antimycotics
Current Clinical Pharmacology Diagnostic Value of the Leukocyte Esterase Test for Early Detection of Pleocytosis in Cerebrospinal Fluid of Patients with Suspected Acute Bacterial Meningitis
Infectious Disorders - Drug Targets Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs
Current Drug Targets